# argenx (ARGX) — Overview

ARGX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/argx

## Price

Last close $846.27 on Oct 15, 2026. 52-week range $663.93 – $1,058.90.

## Company profile

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized myasthenia gravis (gMG). In 2022, Argenx also received FDA approval for Vyvgart Hytrulo, a subcutaneous formulation of Vyvgart, offering a more convenient option compared with Vyvgart's intravenous administration. In 2024, the FDA approved Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy, a rare immune-mediated neuromuscular disorder of the peripheral nervous system. Argenx is focused on innovation and developing its pipeline for treatments such as primary immune thrombocytopenia, thyroid eye disease, and Sjogren's Disease.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $5.3B |
| Revenue (quarter) | $1.5B |
| Revenue growth (year over year) | 59.19% |
| Gross profit (trailing twelve months) | $4.8B |
| Gross margin | 90.15% |
| Net income (trailing twelve months) | $1.7B |
| Net income (quarter) | $472.0M |
| Net income growth (year over year) | 91.87% |
| Net margin | 32.19% |
| Return on equity | 23.63% |
| EPS (trailing twelve months) | $27.75 |
| Book value per share | $134.59 |
| P/E (trailing twelve months) | 30.9 |
| Price to book | 6.3 |
| Debt to assets | 16.10% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is argenx (ARGX) profitable?

Yes. argenx earned $1.7B in net income over the trailing twelve months, a net margin of 32.19%.

### How much revenue does argenx (ARGX) make?

argenx generated $5.3B in revenue over the trailing twelve months, up 59.19% year over year.

### What is ARGX's P/E ratio?

argenx trades at 30.9 times trailing twelve-month earnings, on an EPS of $27.75.

### How do I buy stock in argenx (ARGX)?

ARGX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).